Please login to the form below

Not currently logged in
Email:
Password:

INC Research appoints Jane Winter

She will lead the CRO's global consulting practice

INC Research CRO contract research Jane WinterINC Research has appointed industry veteran Jane Winter to lead its global consulting practice.

She has worked in the industry for 30 years of industry, most recently as interim global head of outsourcing at a Japanese biopharmaceutical company.

Earlier in her career Winter spent 11 years with Quintiles and three year with Wyeth (now part of Pfizer).

She currently serves on the board of directors for the Pan–Asian Clinical Research Association (PACRA), a non-profit organisation in Singapore dedicated to the professional development of clinical research personnel based in Asia Pacific.

As INC's senior vice president of global consulting Winter will be based in the UK and lead the CRO's unit that provides consulting in areas such as drug development and commercialisation and quality assurance.

Alistair Macdonald, INC's chief operating officer, said: “[Jane's] leadership and broad pharmaceutical background will be instrumental as we look to expand our integrated services model to include clinical development optimisation and compliance.

“These additions, combined with our strategy, QA and regulatory practice areas, provide the complete framework to address our customers' most pressing business needs in drug development today.”

26th February 2014

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics